Answers are grounded in this paper and cite their sources.
Clinical evaluation examines sulfonamide chemoprophylaxis against acute respiratory infections in susceptible groups, highlighting antimicrobial approaches to infectious disease prevention.
Article1 January 1945THE EPIDEMIOLOGY OF ACUTE RESPIRATORY INFECTIONS CONDITIONED BY SULFONAMIDES.I. GENERAL CLINICAL CONSIDERATIONS*MORRIS SIEGEL, L. A. JULIANELLEMORRIS SIEGELSearch for more papers by this author, L. A. JULIANELLESearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-22-1-1 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptAlthough an impressive proportion of public health problems associated with prevention of disease has been solved in a gratifying manner, it must be admitted that in the case of respiratory infections as a class prophylaxis remains to be accomplished. Withstanding the attempts made in the past with prophylactic immunization, spraying preparations, personal hygiene, isolation, and, to a limited extent, ultraviolet radiation and aerosols, the still resistant examples of this group of diseases apparently must be controlled by newer methods of approach. It was reflected in this connection that by virtue of their bacteriostatic action, sulfonamides might be of value in...Bibliography1. SIEGEL M: Studies on the control of acute respiratory infections: I. Preliminary report of the oral administration of sulfadiazine at the onset of acute respiratory illnesses, Jr. Am. Med. Assoc., 1942, cxix, 783-785. CrossrefGoogle Scholar2. SIEGEL M: Studies on the control of acute respiratory infections: II. The oral administration of sulfadiazine at the onset of acute respiratory illnesses, Am. Jr. Dis. Child., 1943, lxvi, 114-120. CrossrefGoogle Scholar3. A survey of methods of care, treatment and training of the feebleminded made at Letchworth Village, 1937, State of New York, Department of Mental Hygiene, State Hospital Press, Utica, New York. Google Scholar4. THOMASFRANCE CBR: Preliminary report of the prophylactic use of sulfanilamide in patients susceptible to rheumatic fever, Bull. Johns Hopkins Hosp., 1939, lxiv, 67-77. Google Scholar5. COBURNMOORE AFLV: Prophylactic use of sulfanilamide in streptococcal respiratory infections, with especial reference to rheumatic fever, Jr. Clin. Invest., 1939, xviii, 147-155. CrossrefGoogle Scholar6. COBURNMOORE AFLV: Prophylactic use of sulfanilamide in rheumatic subjects, Med. Clin. N. Am., 1940, xxiv, 633-638. CrossrefGoogle Scholar7. THOMASFRANCEREICHSMAN CBRF: Prophylactic use of sulfanilamide in patients susceptible to rheumatic fever, Jr. Am. Med. Assoc., 1941, cxvi, 551-560. CrossrefGoogle Scholar8. STOWELLBUTTON DDWH: Observation on the prophylactic use of sulfanilamide on rheumatic patients with report of one death, Jr. Am. Med. Assoc., 1941, cxvii, 2164-2166. CrossrefGoogle Scholar9. THOMAS CB: The prophylactic treatment of rheumatic fever by sulfanilamide, Bull. New York Acad. Med., 1942, xviii, 508-526. Google Scholar10. HANSENPLATOUDWAN AERVPF: Prolonged use of a sulfonamide compound in prevention of rheumatic recrudescences in children. An evaluation based on a four year study on sixty-four children, Am. Jr. Dis. Child., 1942, lxiv, 963-976. Google Scholar11. CHANDLERTAUSSIG CAHB: Sulfanilamide as a prophylactic agent in rheumatic fever, Bull. Johns Hopkins Hosp., 1943, lii, 42-53. Google Scholar12. KUTTNERREYERSBACH AGG: The prevention of streptococcal upper respiratory infections and rheumatic re-occurrences in rheumatic children by the prophylactic use of sulfanilamide, Jr. Clin. Invest., 1943, xxii, 77-86. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: New York, N. Y.*Received for publication March 11, 1944.From the Division of Infectious Diseases, The Public Health Research Institute of The City of New York, Inc.Aided by a grant from the Metropolitan Life Insurance Company on the recommendation of the Influenza-Pneumonia Commission.†Died, August 12, 1944. Nextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byFamilial Mediterranean FeverAutoinflammatory DisordersDiffuse and multifocal nephrogenic adenoma with Familial Mediterranean Fever: a case report with molecular studyEffects of M680I and M694V pyrin mutations on the tertiary structure of domain B30.2 and its interaction with caspase-1: In silico analysisEpidemiology of FMF WorldwideHigher thrombin activatable fibrinolysis inhibitor levels are associated with inflammation in attack-free familial Mediterranean fever patientsFamilial Mediterranean FeverFamilial Mediterranean fever in Germany: clinical presentation and amyloidosis riskFamilial Mediterranean Fever and Other Autoinflammatory DisordersHeriditary Immunodeficiency DiseasesAutoinflammatory DisordersThe expanded clinical spectrum of familial Mediterranean feverPulmonary Manifestations in Familial Mediterranean FeverHereditary Periodic FeverDifferential diagnosis of fever of unknown origin in childrenFamilial Mediterranean Fever at the Millennium Clinical Spectrum, Ancient Mutations, and a Survey of 100 American Referrals to the National Institutes of HealthFamilial Mediterranean Fever: The Genetics of InflammationFamilial Mediterranean fever: High gene frequency among the non-Ashkenazic and ashkenazic Jewish populations in IsraelFamilial Mediterranean Fever-Associated AmyloidosisEnhanced neutrophil chemiluminescence in familial mediterranean feverPrimary Hereditary Systemic Amyloidosis (Meretoja's Syndrome): Clinical Features and Treatment by Plastic SurgeryGeneral Introduction and a Brief History of AmyloidosisSchönlein-henoch syndrome in patients with familial mediterranean feverMiscellaneousDas PeritoneumPeriodic peritonitis report of 41 cases without amyloidosisDiseases of Uncertain Aetiology and Environmental Diseases in the TropicsHereditary amyloidosisPeriodische FiebersyndromePeriodic peritonitisThe arthritis of familial mediterranean fever (FMF)Systemic changes during the menstrual cycleThe Sensitivity of Various Bacteria to Chemotherapeutic AgentsDie Krankheiten des BauchfellsAntimicrobial Treatment for Viral and Related InfectionsGastro-intestinal food hypersensitivity: Roentgenographic demonstrationPurpura and IntussusceptionJUVENILE RHEUMATISM: A SURVEY FROM THE CHILDREN'S HOSPITAL, MELBOURNE, WITH AN ADDENDUM ON THE FOLLOW‐UP SYSTEM OF THE ALMONERS OF THE HOSPITALLONDON'S HOSPITALSSULPHONAMIDE PROPHYLAXIS OF RESPIRATORY INFECTIONSTHE EPIDEMIOLOGY OF ACUTE RESPIRATORY INFECTIONS CONDITIONED BY SULFONAMIDES. II. GROSS ALTERATIONS IN THE NASOPHARYNGEAL FLORA ASSOCIATED WITH TREATMENT*L. A. JULIANELLE, MORRIS SIEGELTHE EPIDEMIOLOGY OF ACUTE RESPIRATORY INFECTIONS CONDITIONED BY SULFONAMIDES. III. EFFECTS OF TREATMENT ON THE ORGANISM AND CARRIER OF DIPHTHERIA*L. A. JULIANELLE, MORRIS SIEGELTHE EPIDEMIOLOGY OF ACUTE RESPIRATORY INFECTIONS CONDITIONED BY SULFONAMIDES. IV. TRENDS IN PNEUMOCOCCAL TYPES INITIATED BY DRUG TREATMENT*L. A. JULIANELLE, MORRIS SIEGEL 1 January 1945Volume 22, Issue 1Page: 1-9KeywordsEpidemiologyHygieneInfectious diseasesPrevention, policy, and public healthProphylaxisPulmonary diseasesSulfonamideUpper respiratory tract infections ePublished: 1 December 2008 Issue Published: 1 January 1945 Copyright & PermissionsCopyright, 1945, by The American College of PhysiciansPDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Morris Siegel (1945) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: